Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer revision label has been updated from **v3.5.2** to **v3.5.3**, reflecting a minor update to the site software/display version without altering the underlying study record details.SummaryDifference0.0%

- Check10 days agoChange DetectedCurrent revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded medullary thyroid carcinoma to the conditions list and included Genetic and Rare Diseases Information Center as a resources link.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check47 days agoChange DetectedSite updated from version 3.4.2 to 3.4.3; no changes to study content or user-facing functionality are evident.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice about government funding and the previous Revision: v3.4.1. These are administrative changes and do not affect the study information on the page.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.